We utilized the cBioPortal tool to explore the mutation features of NOP2 in ccRCC from TCGA cohort and noticed that the genetic alteration frequency of NOP2 was less than 1% in ccRCC (Figure 7(a)). This evidence concerns the gene NOP2 and nonpapillary renal cell carcinoma.